A Phase 1 Study of HDM2017 in Advanced Solid Tumors
Clinical trial NCT07274085 · RECRUITING
Trial details
- NCT number
- NCT07274085
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-18
- Primary completion
- 2026-12-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.